Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
03/17/2005 | WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders |
03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
03/17/2005 | US20050059683 A1 adenosine receptor antagonists |
03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
03/17/2005 | CA2536512A1 Rage-related methods and compositions for treating glomerular injury |
03/16/2005 | EP1514869A1 Indole, indazole, and benzazole derivative |
03/16/2005 | EP1514117A1 Methods for avoiding renal injury |
03/16/2005 | EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
03/16/2005 | EP1513831A1 Novel compounds, their use and preparation |
03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
03/16/2005 | EP1513814A1 Novel piperidine compound |
03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
03/16/2005 | EP1513543A2 Fas peptide mimetics and uses thereof |
03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
03/16/2005 | EP1351962B1 Thienopyrimidine |
03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
03/16/2005 | EP0837681B1 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
03/16/2005 | CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
03/16/2005 | CN1593654A Human lysozyme suppository, preparation method and application |
03/16/2005 | CN1593577A Tibetan medical liquor for nourishing kidney |
03/16/2005 | CN1593532A Prostatitis treating capsule and its preparing method |
03/16/2005 | CN1593530A 'Sanjin' dispersible tablet for treating urethritis and its preparing method |
03/16/2005 | CN1593529A Dispersible tablet for treating prostatitis and prostate hyperplasia and its preparation process |
03/16/2005 | CN1593528A Dispersible tablet for treating urination difficulty and its preparation method |
03/16/2005 | CN1593496A Chinese medicine for treating enuresis in children and preparation method thereof |
03/16/2005 | CN1593490A Chinese medicinal compound preparation for treating prostate hyperplasia and preparing process thereof |
03/16/2005 | CN1593477A Chinese herbal medicine for treating chronic prostatitis and its preparation |
03/16/2005 | CN1593475A Novel use for mixture of astragalus root and angelica |
03/16/2005 | CN1593449A self emulsifying soft capsule of breviscapine and its preparation |
03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
03/16/2005 | CN1192794C Medicinal plaster for treating urolithiasis |
03/16/2005 | CN1192769C Medicinal compositions for treating lower uropathy |
03/15/2005 | US6867288 Polycystic kidney disease gene |
03/15/2005 | US6867222 Nociceptin analogs |
03/15/2005 | US6867215 Cardioprotective phosphonates and malonates |
03/15/2005 | US6867214 Quinazoline derivatives and pharmaceutical applications thereof |
03/15/2005 | US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol |
03/15/2005 | US6867200 Anticancer agents; anticoagulants |
03/15/2005 | CA2191769C Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
03/10/2005 | WO2005021506A1 Synthesis of 1-[4-(2-methoxyphenyl) piperazin-1-yl]-3-(2,6-dioxopiperidin-1-yl) propane |
03/10/2005 | WO2005021013A1 β-HYDROXY SHORT TO MEDIUM CHAIN FATTY ACID POLYMER |
03/10/2005 | WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
03/10/2005 | US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics |
03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
03/10/2005 | US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas |
03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
03/10/2005 | US20050054664 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
03/10/2005 | US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders |
03/10/2005 | US20050054593 New drug |
03/10/2005 | US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases |
03/10/2005 | US20050054575 Peptide agonists of prostate-specific antigen and uses therefor |
03/10/2005 | US20050054567 Polypeptides; adjust concentration of stem cells |
03/10/2005 | US20050053931 Method for the diagnosis and therapy of renal cell carcinoma |
03/09/2005 | EP1512415A1 Decoy composition for treating and preventing inflammatory disease |
03/09/2005 | EP1512016A1 Screening method and anti-tumor drug candidate obtained therefrom |
03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
03/09/2005 | EP1511845A2 Immunostimulatory oligonucleotides and uses thereof |
03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
03/09/2005 | EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors |
03/09/2005 | EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators |
03/09/2005 | EP1511737A1 Aryloximes |
03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
03/09/2005 | EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
03/09/2005 | EP1511511A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders |
03/09/2005 | EP1511502A2 Probiotic therapies using lactobacillus reuteri |
03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
03/09/2005 | EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound |
03/09/2005 | EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
03/09/2005 | EP1432407B1 Lisinopril compositions having large-particle dcpd |
03/09/2005 | EP1137423B1 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
03/09/2005 | EP1126849B1 Heterocyclic potassium channel inhibitors |
03/09/2005 | EP1054680B1 Treatment of bladder cancer by mycobacterium phlei cell wall |
03/09/2005 | CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity |
03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
03/09/2005 | CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |